NEVADA
|
001-37761
|
20-5093315
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
343 Allerton Ave.
South San Francisco, California 94090
|
(Address of principal executive offices)
|
|
For
|
Withheld
|
||
|
Votes
|
%
Voted
|
Votes
|
%
Voted
|
Jon S.
Saxe
|
3,922,660
|
95.75
%
|
174,159
|
4.25
%
|
Shawn K.
Singh
|
4,077,051
|
99.52
%
|
19,768
|
0.48
%
|
H.
Ralph Snodgrass
|
3,981,028
|
97.17
%
|
115,791
|
2.83
%
|
Brian J. Underdown
|
4,050,168
|
98.86
%
|
46,651
|
1.14
%
|
Jerry
B. Gin
|
4,050,168
|
98.86
%
|
46,651
|
1.14
%
|
|
For
|
Against
|
Abstain
|
Votes
|
5,864,179
|
243,307
|
510,447
|
% of Total
Outstanding Shares Voted
|
62.71
%
|
2.60
%
|
5.46
%
|
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
Votes
|
3,522,373
|
500,417
|
74,029
|
2,521,114
|
%
Voted
|
85.98
%
|
12.21
%
|
1.81
%
|
|
|
For
|
Against
|
Abstain
|
Votes
|
6,192,477
|
255,945
|
169,511
|
%
Voted
|
93.57
%
|
3.87
%
|
2.56
%
|
|
VistaGen
Therapeutics, Inc.
|
|
|
|
|
Date:
September 20, 2017
|
By:
|
/s/ Shawn K. Singh
|
|
|
Shawn
K. Singh
Chief
Executive Officer
|
Exhibit Number
|
|
Description
|
|
|
|
|
Certificate
of Amendment to the Restated and Amended Articles of Incorporation
of VistaGen Therapeutics, Inc., dated September 15,
2017.
|